Issue |
Title |
File |
Vol 24, No 1 (2022) |
Management of patients with hormone receptor-positive HER2-negative metastatic breast cancer: data of randomized trials and real-world evidence |
(Rus)
|
Editorial B.
|
Vol 21, No 2 (2019) |
Management of the patients with stage I germ cell ovarian tumors |
(Rus)
|
Nechushkina I.V., Nechushkina V.M., Boychenko E.I., Susuleva N.A.
|
Vol 22, No 3 (2020) |
Managing menopausal symptoms in patients with hormone receptor-positive gynecologic cancers |
(Rus)
|
Shabalova O.V., Yureneva S.V., Khokhlova S.V., Gardanova Z.R., Ermakova E.I.
|
Vol 22, No 3 (2020) |
Mantle cell lymphoma |
(Rus)
|
Vorob’ev V.I., Tumian G.S., Falaleeva N.A., Ptushkin V.V., Osmanov E.A., Poddubnaya I.V., Baikov V.V., Kovrigina A.M., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
|
Vol 13, No 4 (2011) |
Master-klass po neyroendokrinnymopukholyam: obzor meropriyatiya |
|
Shukhova A.V.
|
Vol 6, No 4 (2004) |
Materialy VIII Vserossiyskogo onkologicheskogo kongressa |
|
- -.
|
Vol 11, No 1 (2009) |
Media-reliz Vedushchiy mezhdunarodnyy meditsinskiy zhurnal «The Lancet» svidetel'stvuet:Preparat Glivek® znachitel'no snizhaet risk razvitiya retsidivau patsientov s gastrointestinal'nymi stromal'nymi opukholyami |
|
- -.
|
Vol 6, No 2 (2004) |
Meditsinskaya reabilitatsiya bol'nykh rakom i dobrokachestvennymi opukholyami shchitovidnoy zhelezy posle khirurgicheskogo lecheniya |
|
Savenok E.V., Ognerubov N.A., Savenok V.U.
|
Vol 12, No 3 (2010) |
Mekhanizmy mobilizatsii gemopoeticheskikhpredshestvennikov granulotsitarnymkoloniestimuliruyushchim faktorom |
|
Rumyantsev S.A., Balashov D.N., Rumyantsev A.G.
|
Vol 14, No 4 (2012) |
Melanoma kon\"yunktivy: kliniko-morfologicheskie paralleli |
|
Grishina E.E., Nechesnyuk S.Y., Andreychenko A.M.
|
Vol 9, No 1 (2007) |
Melkokletochnyy rak legkogo: chto izmenilos' za poslednie 30 let? |
|
Bychkov M.B.
|
Vol 25, No 3 (2023) |
Membrane (CD8⁺PD-1⁺ and CD4+PD-1⁺) and soluble (sPD-1 and sPD-L1) forms of immune checkpoints in melanoma, breast cancer, and oral mucosal cancer patients: A observational study |
(Rus)
|
Zabotina T.N., Chertkova A.I., Borunova A.A., Kushlinskii N.E., Gershtein E.S., Zakharova E.N., Shoua E.K., Tsiklauri V.T., Samoylenko I.V., Khoroshilov M.V., Kadagidze Z.G.
|
Vol 25, No 3 (2023) |
Memorial lecture to the 100th anniversary of the birth of Professor Yu.I. Lorie |
(Rus)
|
Demina E.A., Poddubnaya I.V.
|
Vol 12, No 1 (2010) |
Mestnorasprostranennyy i metastaticheskiygormonopozitivnyy rak molochnoy zhelezy:problemy terapii i perspektivyprimeneniya lapatiniba v kombinatsiis ingibitorami aromatazy v kachestveterapii pervoy linii |
|
Poddubnaya I.V.
|
Vol 12, No 1 (2010) |
Mestnye gemostaticheskie sredstvav khirurgicheskoy onkogepatologii |
|
Bagmet N.N., Chardarov N.K., Skipenko O.G.
|
Vol 12, No 1 (2010) |
Mesto fulvestranta v endokrinoterapiimetastaticheskogo raka molochnoy zhelezy |
|
Kolyadina I.V., Makarenko N.P., Poddubnaya I.V.
|
Vol 2, No 4 (2000) |
Mesto ingibitorov aromatazy v sovremennoy gormonoterapii raka molochnoy zhelezy - Femara (letrozol) |
|
Perevodchikova N.I.
|
Vol 14, No 3 (2012) |
Mesto khimioterapii i gormonoterapii vo 2-y linii lecheniya kastratsionno-rezistentnogo raka predstatel'noy zhelezy |
|
Rusakov I.G., Gritskevich A.A., Mishugin S.V.
|
Vol 3, No 2 (2001) |
Mesto khimioterapii v sisteme lecheniya onkologicheskikh bol'nykh i vybor terapevticheskoy taktiki |
|
Perevodchikova N.I.
|
Vol 12, No 3 (2010) |
Mesto konservativnoy terapiiv lechenii raka slizistoy obolochki shcheki |
|
Udintsov D.B., Kropotov M.A., Sobolevskiy V.A., Dobrokhotova V.Z.
|
Vol 12, No 2 (2010) |
Mesto Taksotera v terapiimetastaticheskogo raka molochnoy zhelezy |
|
Artamonova E.V.
|
Vol 11, No 3 (2009) |
Mesto tsetuksimaba v terapii metastaticheskogo raka tolstoy kishki |
|
Artamonova E.V.
|
Vol 9, No 1 (2007) |
Mesto UZT pri planirovanii lecheniya zlokachestvennykh epitelial'nykh opukholey yaichnikov |
|
Chekalova M.A., Poddubnaya I.V., Mazyrko M.A., Sinitsina M.E.
|
Vol 22, No 3 (2020) |
Meta-analysis of the studies dedicated to the predictive significance of circulating tumor DNA in pancreatic cancer |
(Rus)
|
Popova A.S., Fedyanin M.Y., Pokataev I.A., Tyulyandin S.A.
|
Vol 23, No 2 (2021) |
Metastatic cervical cancer: clinical experience with pembrolizumab application. Case report |
(Rus)
|
Protasova A.E., Strakh L.V., Lando E.I., Sidorkina E.V.
|
Vol 23, No 4 (2021) |
Metastatic gastrointestinal stromal tumor of the greater omentum. Case report |
(Rus)
|
Yugay V.V., Nikulin M.P., Mazurenko N.N., Mochal'nikova V.V., Filonenko D.A., Meshherjakov A.A., Bugaev V.E., Arhiri P.P., Stroganova A.M., Stilidi I.S.
|
Vol 22, No 3 (2020) |
Metastatic renal cell carcinoma of unknown primary site. Clinical follow-up |
(Rus)
|
Ognerubov N.A., Antipova T.S., Gumareva G.E.
|
Vol 11, No 1 (2009) |
Metastaticheskoe porazhenie myagkikh tkaney peredney bryushnoy stenki (Opisanie klinicheskogo sluchaya) |
|
Kolyadina I.V., Komov D.V., Roshchin E.M., Ognerubova I.N.
|
Vol 4, No 3 (2002) |
Metod protochnoy DNK-tsitometrii v prognozirovanii klinicheskogo techeniya raka slizistoy obolochki polosti rta i gortani |
|
Nikolaeva T.G., Akhundov A.A., Podvyaznikov S.O., Dobrynin Y.V.
|
Vol 6, No 2 (2004) |
Metodika sochetannoy luchevoy terapii rasprostranennykh form raka sheyki matki v usloviyakh khimicheskoy poliradiomodifikatsii |
|
Kostromina K.N., Razumova E.L., Korotkikh N.V., Besedina E.L., Kravets B.B.
|
Vol 13, No 1 (2011) |
Metody regionarnoy terapii metastaticheskikh opukholey pecheni:tselesoobraznost' primeneniya embolizatsii pechenochnykh arteriy |
|
Kogoniya L.M., Yakusheva T.A., Bayramov E.T., Fedotov A.Y., Severtsev A.N., Grishina I.M.
|
Vol 7, No 3 (2005) |
Mezotelioma plevry: sovremennaya taktika lecheniya |
|
Bychkov M.B., Bol'shakova S.A., Bychkov Y.M.
|
Vol 8, No 1 (2006) |
Minimal'naya ostatochnaya bolezn' pri V-kletochnom khronicheskom limfoleykoze |
|
Nikitin E.A., Gretsov E.M.
|
Vol 13, No 3 (2011) |
Minzdravsotsrazvitiya RF: predlozhenieobshchestva po spisku ZhNVLP poluchilo odobrenie |
|
- -.
|
Vol 18, No 5 (2016) |
Missions and potentialities of municipal oncohematological service |
|
Ptushkin V.V.
|
Vol 6, No 1 (2004) |
Mnozhestvennaya mieloma : dostizheniya lekarstvennogo lecheniya XX-XX I vekov |
|
Votyakova Y.M.
|
Vol 16, No 1 (2014) |
Mobilization of hematopoietic stem cells (HSCs) by using Pleriksafor (Mozobail) in combinationwith colony-stimulating factor in patients with previous failure transplant procurement for autotransplantation of HSCs |
|
Mikhailova N.B., Alianskij A.L., Kondakova E.V., Zalyalov U.R., Babenko E.V., Sergeev V.S., Estrina M.A., Kucher M.A., Kulagin A.D., Borzenkova E.S., Afanasiev B.V.
|
Vol 24, No 3 (2022) |
Modern approaches in relapsed and refractory Hodgkin lymphoma treatment: literature review and own experience |
(Rus)
|
Tsaplina N.S., Valiev T.T., Petrova G.D., Kirgizov K.I., Varfolomeeva S.R.
|
Vol 23, No 1 (2021) |
Modern approaches in the first line treatment of CD30-positive peripheral T-cell lymphomas |
(Rus)
|
Poddubnaya I.V., Bariakh E.A., Voloshin S.V., Gorenkova L.G., Kaplanov K.D., Kovrigina A.M., Mikhailova N.B., Pospelova T.I., Ptushkin V.V., Tumian G.S., Falaleeva N.A., Khusainova G.N.
|
Vol 23, No 2 (2021) |
Modern approaches to the diagnosis of malignant trophoblastic tumors |
(Rus)
|
Mamedli S.N., Chekalova M.A., Meshcheriakova L.A.
|
Vol 23, No 2 (2021) |
Modern approaches to the therapy of invasive mycoses in cancer patients |
(Rus)
|
Prikhodchenko A.O., Nechuskina V.M., Vyatkin P.V.
|
Vol 17, No 5 (2015) |
Modern aspects of differential diagnosis and treatment of large B-cell lymphomas with mediastinum involvement in children and adolescents |
|
Levashov A.S., Kovrigina A.M., Stroganova A.M., Valiev T.T., Belyaeva E.S., Popa A.V., Mentkevich G.L.
|
Vol 21, No 4 (2019) |
Modern immunological criteria for a stratification of risk groups for precursor B cell acute lymphoblastic leukemia in children |
(Rus)
|
Shervashidze M.A., Valiev T.T., Batmanova N.A., Tupitsyn N.N., Serebryakova I.N.
|
Vol 16, No 3 (2014) |
Modern options in personalized therapy of metastatic cutaneous melanoma |
|
Protsenko S.A., Novik A.V., Akhaeva Z.Y., Zhabina A.S., Imyanitov E.N., Semenova A.I.
|
Vol 22, No 3 (2020) |
Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib |
(Rus)
|
Sekacheva M.I., Nuriev R.I., Rozhkov A.A., Semenkov A.V., Bagmet N.N., Boroda A.M.
|
Vol 16, No 4 (2014) |
Modern possibilities of HER2 positive breast cancer treatment (based on clinical trials) |
|
Kolyadina I.V., Poddubnaya I.V.
|
Vol 23, No 2 (2021) |
Modern possibilities of immunotherapy in the treatment of extensive-stage small cell lung cancer: experience of durvalumab application. Case report |
(Rus)
|
Zhabina A.S., Moiseenko F.V., Volkov N.M., Abduloeva N.K., Moiseenko V.M.
|
Vol 22, No 4 (2020) |
Modern possibilities of radiological diagnosis of bladder cancer |
(Rus)
|
Suchilova M.M., Nikolaev A.E., Shapiev A.N., Mukhutdinova G.Z., Tkacheva P.V., Nikiforova M.V., Gombolevskiy V.A., Morozov S.P.
|
Vol 17, No 4 (2015) |
Modern possibilities of targeted therapy in metastatic colorectal cancer |
|
Gorbunova V.A.
|
Vol 23, No 3 (2021) |
Modern possibilities of therapy for primary cutaneous T-cell lymphomas: the first results of the use of brentuximab vedotin in the Russian Federation |
(Rus)
|
Gorenkova L.G., Belousova I.E., Kravchenko S.K., Kovrigina A.M., Sidorova Y.V., Ryzhikova N.V., Lepik E.E., Shneyder T.V.
|
Vol 20, No 4 (2018) |
Modern radiation therapy in part of treatment primary mediastinal (thymic) B-large cell lymphoma (results of 131 patients treated at N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation) |
(Rus)
|
Trofimova O.P., Zavodnova I.Z., Tumyan G.S., Pryamikova Y.I., Volkova N.V., Zaichenko O.S., Nazarenko A.V.
|
Vol 24, No 2 (2022) |
Modern strategy of treatment of patients with retroperitoneal sarcomas: A review |
(Rus)
|
Stilidi I.S., Nikulin M.P., Kalinin O.E., Abgiarian M.G., Vashakmadze L.V., Fainshtein I.A., Arkhiri P.P., Salimova A.A.
|
Vol 16, No 2 (2014) |
Modern technology of radiation therapy: IMRT, VMAT using simultanting integrated boost (SIB) in the complex treatment of squamous cell carcinoma of the anal canal |
|
Tkachev S.I., Glebovskaya V.V., Rasulov A.O., Tsariuk V.F., Aliev V.A., Vodyanik V.V.
|
Vol 18, No 3 (2016) |
Modern therapy of radioactive iodine-refractory differentiated thyroid cancer: resolution of the Expert Council |
(Rus)
|
Rumyantsev P.O., Gorbunova V.A., Podvyaznikov S.O., Zhukov N.V., Isaev P.A., Krylov V.V., Mudunov A.M., Rodichev A.A., Shavarova E.K.
|
Vol 16, No 3 (2014) |
Modern treatment possibilities of hormone receptor-positive advanced breast cancer in postmenopausal women |
|
Jackisch C., Llombart-Cussac A.
|
Vol 21, No 2 (2019) |
Modern ultrasound diagnostics for locally advanced cervical cancer |
(Rus)
|
Ovodenko D.L., Khabas G.N., Makarova A.S., Pirogova M.S., Seregin A.A., Golitsyna Y.S., Ashrafyan L.A.
|
Vol 21, No 3 (2019) |
Modern ultrasound technologies in monitoring the effectiveness of chemotherapy for cervical cancer |
(Rus)
|
Musaeva Z.R., Chekalova M.A., Mesheryakov A.A.
|
Vol 22, No 1 (2020) |
Modern view on the issues of diagnosis and verification of axillary lymph nodes involvement in early breast cancer |
(Rus)
|
Kolyadina I.V., Danzanova T.Y., Khokhlova S.V., Trofimova O.P., Kovaleva E.V., Rodionov V.V., Poddubnaya I.V.
|
Vol 15, No 2 (2013) |
Molecular aspects of the development of genetic syndromes associated with pancreatic neuroendocrine tumors |
|
Mayev I.V., Andreyev D.N., Kucheryavyi Y.A., Dicheva D.T., Andreyeva T.A.
|
Vol 19, No 1 (2017) |
Molecular characteristics of premalignant breast lesions |
(Rus)
|
Vysotskaya I.V., Letyagin V.P., Pogodina E.M.
|
Vol 18, No 4 (2016) |
Molecular genetic features of the head and neck (upper aerodigestive tract) mucosal melanoma |
|
Ignatova A.V.
|
Vol 25, No 3 (2023) |
Molecular genetic markers of ovarian cancer tumor cells and their microenvironment, study methods, and clinical value: A review |
(Rus)
|
Kalfa M.A., Golovkin I.O., Lazarev A.E., Golubinskaya L.P., Gritskevich O.Y., Zyablitskaya E.Y.
|
Vol 22, No 3 (2020) |
Molecular genetic portrait of non-small cell lung cancer in Tambov region: regional experience |
(Rus)
|
Ognerubov N.A., Sychev V.D., Kozlova N.A., Chang V.L.
|
Vol 21, No 1 (2019) |
Molecular-biological marker Bcl-2 in colorectal cancer: the characteristics, the role of mechanisms regulating apoptosis, the effect on the prognosis (review of literature) |
(Rus)
|
Darenskaia A.D., Dobrova N.V., Stepanova E.V.
|
Vol 25, No 1 (2023) |
Molecular-genetic landscape of abdominal and retroperitoneal desmoid fibromatosis: a retrospective study |
(Rus)
|
Turupaev K.A., Budurova M.D., Filippova M.G., Isayev A.A., Gridneva Y.V., Khmelkova D.N., Gayryan M.A., Mironova I.V., Nikulin M.P., Puchkova A.I., Delektorskaya V.V.
|
Vol 17, No 3 (2015) |
Molekulyarnaya biologiya i osnovnye geneticheskie narusheniya pri melanome |
|
Demidova I.A.
|
Vol 8, No 1 (2006) |
Molekulyarno-biologicheskie faktory prognoza pri B-kletochnom khronicheskom limfoleykoze |
|
Nikitin E.A., Malakho S.G., Biderman B.V., Poltaraus A.B., Sudarikov A.B.
|
Vol 9, No 4 (2007) |
Molekulyarno-biologicheskie markery v khimioterapevticheskom lechenii metastaticheskogo kolorektal'nogo raka |
|
Kuznetsova E.A., Eropkin P.V., Kashnikov V.N.
|
Vol 12, No 4 (2010) |
Molekulyarnyy monitoringeffektivnosti terapii bol'nykhkhronicheskim mieloleykozom v Rossii(po materialam Vserossiyskoy nauchno-prakticheskoykonferentsii, Irkutsk, 3-4 sentyabrya 2010 g.) |
|
Dubina M.V., Kuevda D.A., Khomyakova T.E., Tsaur G.A., Kutsev S.I., Zaritskiy A.Y.
|
Vol 8, No 4 (2006) |
Morfoimmunologicheskaya kharakteristika porazheniya kostnogo mozga pri diffuznoy V-kletochnoy krupnokletochnoy limfome |
|
Chigrinova E.V., Pavlovskaya A.I., Tupitsyn N.N.
|
Vol 14, No 4 (2012) |
Moskva, 5 noyabrya. VII Forum ekspertov po diagnostike i lecheniyu raka molochnoy zhelezy (Rim, 2-5 noyabrya 2012 g.) |
|
- -.
|
Vol 13, No 3 (2011) |
Mul'tidistsiplinarnyy podkhodk diagnostike i lecheniyu raka molochnoyzhelezy - vpervye na Forume ekspertov |
|
- -.
|
Vol 23, No 4 (2021) |
Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON |
(Rus)
|
Tryakin A.A., Fedyanin M.Y., Moiseenko F.V., Mironov O.V., Stroyakovskiy D.L., Sokolov N.I., Orlova S.A., Mantsyrev E.O., Sultanbaev A.V., Teterich A.A., Babina K.G., Yukalchuk D.Y., Borzyanitsa S.M., Isyangulova A.Z., Saidullaeva A.F., Chernova Y.A., Bobrova E.A., Fadeeva N.V., Chobanu D.Y.
|
Vol 24, No 3 (2022) |
Multidisciplinary interaction of Russian professional communities in oncology |
(Rus)
|
Khatkov I.Е., Andreyashkina I.I., Zelenova E.E., Trotsenko I.D.
|
Vol 17, No 3 (2015) |
Multimodal approach to the treatment of hepatocellular carcinoma |
|
Skipenko O.G., Chekunov D.A., Shatverian G.A., Bagmet N.N., Sekacheva M.I., Polyakov R.S., Bedzhanyan A.L., Abdullaev A.G., Moysyuk Y.G.
|
Vol 22, No 4 (2020) |
Multiple myeloma |
(Rus)
|
Mendeleeva L.P., Votiakova O.M., Rekhtina I.G., Osmanov E.A., Poddubnaya I.V., Grivtsova L.I., Falaleeva N.A., Baikov V.V., Kovrigina A.M., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
|
Vol 12, No 1 (2010) |
Myustoforan pri lecheniidisseminirovannoy melanomy kozhii glial'nykh opukholey golovnogo mozga |
|
Kudryavtseva G.T., Kudryavtsev D.V.
|
Vol 13, No 1 (2011) |
Na IV forume Dvizhenie protiv raka predlozheno sozdat' programmu Natsional'noy strategiisnizheniya smertnosti ot onkologicheskikh zabolevaniy |
|
- -.
|
Vol 12, No 3 (2010) |
Na territorii Rossiyskoy FederatsiiGertseptin zaregistrirovan v kachestve terapiirasprostranennoy adenokartsinomy zheludkaili pishchevodno-zheludochnogo perekhodas opukholevoy giperekspressiey HER2 |
|
- -.
|
Vol 3, No 2 (2001) |
Narusheniya pamyati u bol'nykh solidnymi zlokachestvennymi opukholyami vo vremya khimioterapii |
|
Shakirova I.N., Zaguzina N.N., Setdikov R.A.
|
Vol 14, No 1 (2012) |
Nasledstvennyy rak yaichnika(literaturnyy obzor) |
|
Kazakov M.P., Poddubnaya I.V., Lyubchenko L.N., Kharitonova T.V.
|
Vol 8, No 2 (2006) |
Nasledstvennyy rak zheludka: molekulyarno-geneticheskie i klinicheskie aspekty |
|
Nikulin M.P., Lyubchenko L.N., Sel'chuk V.Y., Stilidi I.S.
|
Vol 10, No 4 (2008) |
Natulan pri lechenii limfomy Khodzhkina: ot MORR do VEASORR |
|
Demina E.A.
|
Vol 12, No 1 (2010) |
Nauchno-prakticheskaya konferentsiya«Profilaktika i lechenie trombozovven i tromboemboliy u bol'nykhs onkologicheskimi zabolevaniyami» |
|
- -.
|
Vol 2, No 2 (2000) |
Navel'bin v kombinatsii s doksorubitsinom v terapii I linii u bol'nykh pervichno-disseminirovannym i metastaticheskim rakom molochnoy zhelezy (predvaritel'nye dannye) |
|
Arkad'eva T.V., Davidenko I.S., Rozenbaum P., Poddubnaya I.V.
|
Vol 1, No 2 (1999) |
Neepitelial'nye opukholi golovy i shei. Problemy vchera, segodnya, zavtra |
|
Podvyaznikov S.O.
|
Vol 3, No 4 (2001) |
Nefroblastoma - test-ob\"ekt detskoy opukholi |
|
Durnov L.A., Sharoev T.A., Lebedev V.I., Kozlova V.M.
|
Vol 12, No 3 (2010) |
Nekhodzhkinskie limfomy kishechnika -pervichnoe ekstranodal'noe porazhenie |
|
Suanova Z.A., Shalenkov V.A., Nered S.N., Poddubnaya I.V.
|
Vol 8, No 1 (2006) |
Nekhodzhkinskie limfomy marginal'noy zony |
|
Poddubnaya I.V., Moskalenko O.A., Balakireva Y.N.
|
Vol 8, No 1 (2006) |
Nekhodzhkinskie limfomy mochepolovoy sistemy |
|
Bogdanov A.N., Maksimov A.G., Anosov N.A., Krivolapov Y.A.
|
Vol 6, No 2 (2004) |
Nekotorye aspekty sovershenstvovaniya upravleniya kachestvom onkologicheskoy pomoshchi |
|
Kravets B.B., Pripachkina A.P., Gromova E.V., Klimova N.I.
|
Vol 8, No 4 (2006) |
Nekotorye prognosticheskie faktory pri sovremennoy terapii khronicheskogo limfoleykoza |
|
Byalik T.E., Grivtsova L.Y., Karseladze A.I., Zagoskina T.P., Bessmel'tsev S.S., Volkova M.A.
|
Vol 11, No 2 (2009) |
Neksavar® (sorafenib)v lechenii rasprostranennogo pochechno-kletochnogo raka |
|
Podregul'skiy K.E.
|
Vol 24, No 3 (2022) |
Neoadjuvant chemotherapy for treatment patients with rectal cancer with adverse prognostic factors: A review |
(Rus)
|
Nevolskikh A.A., Avdeenko V.A., Belokhvostova A.S., Mikhaleva Y.Y., Pochuev T.P., Zibirov R.F., Ivanov S.A., Kaprin A.D.
|
Vol 17, No 4 (2015) |
Neoadjuvant systemic therapy of HER2-positive breast cancer |
|
Frolova M.A.
|
Vol 5, No 1 (2003) |
Neoad\"yuvantnaya khimioterapiya pri zlokachestvennykh opukholyakh yaichnikov: "za " i "protiv " |
|
Novikova E.G., Korneeva I.A.
|
Vol 2, No 4 (2000) |
Neoad\"yuvantnaya sistemnaya terapiya v kompleksnom lechenii mestnorasprostranennogo raka molochnoy zhelezy |
|
Abashin S.Y.
|
Vol 23, No 3 (2021) |
Network meta-analysis for clinicians |
(Rus)
|
Bogdanov A.A., Bogdanov A.A.
|
Vol 21, No 3 (2019) |
Neuroendocrine carcinoma of the prostate (review of the literature) |
(Rus)
|
Abbasova D.V., Polikarpova S.B., Kozlov N.A., Baranova M.P., Kovalenko I.P., Ignatova E.I.
|
Vol 26, No 1 (2024) |
Neuroendocrine tumor of thymus with ectopic production of adrenocorticotropic hormone in a 13-year-old child. Case report, 5-year follow-up |
(Rus)
|
Slashchuk K.I., Reinberg M.V., Bazarova E.A., Kareva M.A., Przhiyalkovskaya E.G., Degtiarev M.V., Pikin O.V.
|
501 - 600 of 1319 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >> |